Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anna M. Tanasijevic"'
Autor:
Leah Ferrucci, Tara B. Sanft, Maura Harrigan, Brenda Cartmel, Fangyong Li, Michelle Zupa, Courtney McGowan, Leah Puklin, Thai Hien Nguyen, Anna M. Tanasijevic, Marian L. Neuhouser, Dawn Hershman, Karen Basen-Engquist, Beth Jones, Tish Knobf, Anees B. Chagpar, Andrea L.M. Silber, Jennifer A. Ligibel, Melinda L. Irwin
Publikováno v:
Cancer Research. 83:PD12-08
Background: Neoadjuvant chemotherapy is available to women with locally advanced breast cancer where chemotherapy is given prior to surgery. By examining resected tissue following neoadjuvant chemotherapy pathological complete response (pCR) can be d
Publikováno v:
Supportive Care in Cancer. 31
Autor:
Meghan Acosta, Juliana Berfield, Jennifer A. Ligibel, Carolyn S. Phillips, Robert Knoerl, Anna M. Tanasijevic, Heather Woods
Publikováno v:
Supportive Care in Cancer
s The outbreak of the coronavirus disease 2019 (COVID-19) and subsequent need for disease transmission mitigation efforts have significantly altered the delivery of cancer care (e.g., rise of telemedicine), including within the field of integrative o
Autor:
Richard J. Chen, Robert J. Soiffer, Liying Zhang, Anna M. Tanasijevic, Jane A. Driver, Lee Mozessohn, Gregory A. Abel, Andrew Keezer, Jorge J. Castillo, Rena Buckstein, Oreofe O. Odejide
Publikováno v:
Leukemialymphoma. 62(12)
Background: Frailty is associated with poor tolerance to chemotherapy and mortality. While recent evidence suggests measures of frailty such as gait speed predict survival in older patients with hematologic malignancies such as lymphoma (Liu, Blood,
Autor:
Marie Sebert, Amy E. DeZern, Anna M. Tanasijevic, Mikkael A. Sekeres, Richard Stone, Courtney D. DiNardo, Heidi D. Klepin, Danielle M. Townsley, Richard J. Chen, Anna Revette, Emily S. Magnavita, Amer M. Zeidan, Gregory A. Abel
Publikováno v:
Leukemia & Lymphoma
The anemia of MDS often results in decreased quality of life, which is invoked to justify red cell transfusions; however, there are sparse data regarding the minimum hemoglobin (Hb) at which it is safe to forgo transfusions for patients with no evide
Autor:
Tammy T. Hshieh, Robert J. Soiffer, Clark DuMontier, Jane A. Driver, Richard Stone, Zilu Zhang, Gregory A. Abel, Anna M. Tanasijevic, Richard J. Chen, Lee Mozessohn, Hajime Uno
Publikováno v:
Blood. 134:67-67
Background: Although frailty influences outcomes in hematologic oncology, little is known about the feasibility and impact of embedded geriatric consultation for frail older adults with blood cancers. Methods: From February of 2015 until May 2018, al
Autor:
Anand R. Habib, Mark M. Awad, Anna M. Tanasijevic, Zilu Zhang, Oreofe O. Odejide, Richard J. Chen, Gregory A. Abel
Publikováno v:
Journal of Clinical Oncology. 37:33-33
33 Background: Recent advances for late-stage lung cancer may have led to a shift from therapeutic ‘nihilism’ to ‘optimism’ (Temel, JCO 2016). It is not known whether this shift has increased prognostic uncertainty nor whether oncologists’